FR2834213B1 - Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations - Google Patents

Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations

Info

Publication number
FR2834213B1
FR2834213B1 FR0116916A FR0116916A FR2834213B1 FR 2834213 B1 FR2834213 B1 FR 2834213B1 FR 0116916 A FR0116916 A FR 0116916A FR 0116916 A FR0116916 A FR 0116916A FR 2834213 B1 FR2834213 B1 FR 2834213B1
Authority
FR
France
Prior art keywords
alkanolamide
cosmetic
inhibiting
pharmaceutical composition
cell migration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0116916A
Other languages
English (en)
Other versions
FR2834213A1 (fr
Inventor
Philippe Msika
Nathalie Piccardi
Antoine Piccirilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Pharmascience SA
Original Assignee
Laboratoires Pharmascience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0116916A priority Critical patent/FR2834213B1/fr
Application filed by Laboratoires Pharmascience SA filed Critical Laboratoires Pharmascience SA
Priority to PCT/FR2002/004582 priority patent/WO2003055462A2/fr
Priority to EP02799126.4A priority patent/EP1458347B1/fr
Priority to KR10-2004-7010260A priority patent/KR20040094402A/ko
Priority to US10/499,977 priority patent/US20050075397A1/en
Priority to JP2003556040A priority patent/JP4898089B2/ja
Priority to CA002472121A priority patent/CA2472121A1/fr
Priority to CN028276833A priority patent/CN1617703B/zh
Priority to AU2002364348A priority patent/AU2002364348A1/en
Publication of FR2834213A1 publication Critical patent/FR2834213A1/fr
Application granted granted Critical
Publication of FR2834213B1 publication Critical patent/FR2834213B1/fr
Priority to MXPA04006420A priority patent/MXPA04006420A/es
Priority to US11/411,870 priority patent/US8304453B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
FR0116916A 2001-12-27 2001-12-27 Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations Expired - Lifetime FR2834213B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0116916A FR2834213B1 (fr) 2001-12-27 2001-12-27 Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations
AU2002364348A AU2002364348A1 (en) 2001-12-27 2002-12-27 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
KR10-2004-7010260A KR20040094402A (ko) 2001-12-27 2002-12-27 랑게르한스 세포 이동을 억제하기 위한 적어도 1개의알칸올아미드를 포함하는 조성물, 및 이의 용도
US10/499,977 US20050075397A1 (en) 2001-12-27 2002-12-27 Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof
JP2003556040A JP4898089B2 (ja) 2001-12-27 2002-12-27 ランゲルハンス細胞の遊走を阻害するための少なくとも一種のアルカノールアミドを含んでなる組成物およびその使用
CA002472121A CA2472121A1 (fr) 2001-12-27 2002-12-27 Composition comprenant au moins un alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations.
PCT/FR2002/004582 WO2003055462A2 (fr) 2001-12-27 2002-12-27 Composition comprenant au moins un alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations.
EP02799126.4A EP1458347B1 (fr) 2001-12-27 2002-12-27 Composition comprenant au moins un alcanolamide pour inhiber la migration des cellules de langerhans et ses utilisations
CN028276833A CN1617703B (zh) 2001-12-27 2002-12-27 包括至少一种链烷醇酰胺以抑制朗格汉斯细胞迁移的组合物及其应用
MXPA04006420A MXPA04006420A (es) 2001-12-27 2004-06-28 Composicion que comprende al menos una alcanolamida para inhibir la migracion de las celulas de langerhans y usos de la misma.
US11/411,870 US8304453B2 (en) 2001-12-27 2006-04-27 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0116916A FR2834213B1 (fr) 2001-12-27 2001-12-27 Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations

Publications (2)

Publication Number Publication Date
FR2834213A1 FR2834213A1 (fr) 2003-07-04
FR2834213B1 true FR2834213B1 (fr) 2004-06-04

Family

ID=8871015

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0116916A Expired - Lifetime FR2834213B1 (fr) 2001-12-27 2001-12-27 Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations

Country Status (10)

Country Link
US (2) US20050075397A1 (fr)
EP (1) EP1458347B1 (fr)
JP (1) JP4898089B2 (fr)
KR (1) KR20040094402A (fr)
CN (1) CN1617703B (fr)
AU (1) AU2002364348A1 (fr)
CA (1) CA2472121A1 (fr)
FR (1) FR2834213B1 (fr)
MX (1) MXPA04006420A (fr)
WO (1) WO2003055462A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2847473B1 (fr) 2002-11-25 2007-06-29 Expanscience Lab Composition comprenant au moins une oxazolidinone, son utilisation cosmetique et comme medicament
JP2006206538A (ja) * 2005-01-31 2006-08-10 Institute Of Physical & Chemical Research 抗原提示細胞の機能制御剤
JP4965807B2 (ja) * 2005-03-30 2012-07-04 日光ケミカルズ株式会社 外用剤用組成物およびそれを含有する皮膚外用剤
AU2006286497A1 (en) * 2005-08-31 2007-03-08 Serentis Limited Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with Staphylococcus aureus
JP2007269671A (ja) * 2006-03-30 2007-10-18 Redox Bioscience Inc アレルギー性皮膚炎の予防ないし治療剤
FR2908650B1 (fr) * 2006-11-16 2012-05-25 Lvmh Rech Utilisation d'une alkyloxazolidinone comme agent cosmetique hydratant et procede d'hydratation de la peau.
IL187247A0 (en) * 2007-11-08 2008-12-29 Hadasit Med Res Service Novel synthetic analogs of sphingolipids
JP6480839B2 (ja) * 2015-09-25 2019-03-13 富士フイルム株式会社 セラミド分散組成物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US138177A (en) * 1873-04-22 Improvement in box-openers
US101580A (en) * 1870-04-05 Improved device for ringing street-car bells
US215414A (en) * 1879-05-13 Improvement in paper-damping machines
US59447A (en) * 1866-11-06 Improvement in churn and washing-machine combined
US4876249A (en) 1987-01-12 1989-10-24 Rajadhyaksha Vithal J Compositions and method comprising heterocyclic compounds containing two heteroatoms
US5235076A (en) * 1991-05-28 1993-08-10 University Of Hawaii Azulenic retinoid compounds, compositions and methods
WO1995029151A1 (fr) * 1994-04-27 1995-11-02 Gist-Brocades B.V. Derives de ceramides a base d'acide 2-hydroxycarboxylique a chaine courte
EP0741562A1 (fr) * 1994-11-28 1996-11-13 Gist-Brocades B.V. Application topique de ceramides
KR19980034991A (ko) * 1996-11-11 1998-08-05 안용찬 비천연세라미드 관련화합물 및 이를 함유하는 피부외용제
JP2001510487A (ja) * 1997-12-05 2001-07-31 デーエスエム ナムローゼ フェンノートシャップ 遊離スフィンゴイド塩基及びセラミドの組合せを含む組成物並びにその使用
CA2320117A1 (fr) * 1998-02-12 1999-08-19 Emory University Derives de sphingolipides et procedes d'utilisation
US6218113B1 (en) * 1998-02-24 2001-04-17 Incyte Genomics, Inc. Human protein kinase C inhibitor
FR2780727B1 (fr) * 1998-07-03 2000-09-08 Atochem Elf Sa Compositions cosmetiques, nouveaux analogues de ceramides a activite anti-elastase, procede de preparation et utilisations
DE19841794A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Ceramide und Sphingosine und Derivate) und Mikrobiziden
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
FR2792202B1 (fr) * 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
US6630163B1 (en) * 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
KR100404072B1 (ko) * 2001-03-12 2003-11-03 주식회사 두산 광범위 피부질환 치료용 조성물
FR2826011B1 (fr) * 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique

Also Published As

Publication number Publication date
CN1617703B (zh) 2010-12-01
MXPA04006420A (es) 2004-10-04
EP1458347A2 (fr) 2004-09-22
KR20040094402A (ko) 2004-11-09
US8304453B2 (en) 2012-11-06
AU2002364348A1 (en) 2003-07-15
EP1458347B1 (fr) 2016-09-28
CA2472121A1 (fr) 2003-07-10
AU2002364348A8 (en) 2003-07-15
US20060194881A1 (en) 2006-08-31
JP2005518390A (ja) 2005-06-23
JP4898089B2 (ja) 2012-03-14
FR2834213A1 (fr) 2003-07-04
WO2003055462A3 (fr) 2004-01-22
US20050075397A1 (en) 2005-04-07
WO2003055462A2 (fr) 2003-07-10
CN1617703A (zh) 2005-05-18

Similar Documents

Publication Publication Date Title
ATE300533T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
FR2834216B1 (fr) Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations
ID22973A (id) Komposisi farmasi dari pemberian oral dari turunan n-piperidino-3-pirazolkarboksamida, garam-garam dan solvatnya
DE69917957D1 (de) Blockcopolymerzusammensetzung für die Modifikation von Asphalt, und Asphaltzusammensetzung enthaltend diese Blockcopolymerzusammensetzung
BR9809691A (pt) Usos de substâncias de óleo
FR2811552B1 (fr) Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
DK0920441T3 (da) 7alfa-(epsilon-aminoalkyl)-estratriener, fremgangsmåde til deres fremstilling, farmaceutiske præparater, som indeholder disse 7-alfa-(epsilon-aminoalkyl)-estratriener, samt deres anvendelse til fremstilling af lægemidler
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
DZ2979A1 (fr) Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
MA27036A1 (fr) Ligands des recepteurs de 5-ht et leurs utilisations
DE60125797D1 (de) Impfstoffzusammesetzung
FR2786075B1 (fr) Conditionnement etanche pour compositions cosmetiques et/ou pharmaceutiques
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
CH689805A8 (fr) Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ATE312090T1 (de) 4-(piperidyl- und pyrrolidyl-alkyl-ureido)- chinoline als urotensin ii rezeptor antagonisten
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2760972B1 (fr) Utilisation de l-citrulline en medecine orthomoleculaire pour la vasoprotection, le tonus relaxatif des muscles lisses et la protection cellulaires
FR2834213B1 (fr) Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations
MA26487A1 (fr) Heterocyclecetohydrazides inhibiteurs de proteases, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
PT1228097E (pt) Actividade antimicrobiana do primeiro grupo cationico da lactoferrina humana
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
FR2787798B1 (fr) Nouvelles particules de polysiloxane et leur application comme agents cosmetiques

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20